Back to Journals » Cancer Management and Research » Volume 13

Review

Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors

       
Total article views   HTML views PDF downloads Totals
3,774 Dovepress* 3,501+ 214 3,715
PubMed Central* 273 90 363
Totals 3,774 304 4,078
*Since 4 October 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar